BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits.
|
Exhibit No. |
Description |
|
10.1* |
Stock Purchase Agreement and Plan of Reorganization dated September 26, 2018, regarding Clyra Medical Technologies, Inc. |
|
10.2 |
Promissory note dated December 17, 2018, issued by Clyra Medical Technologies, Inc., to Scion Solutions, LLC. |
|
10.3** |
Escrow Agreement dated September 26, 2018 |
|
10.4 |
Closing Agreement between Clyra Medical Technologies, Inc., and Scion Solutions, LLC, dated December 17, 2018 |
|
99.1 |
Press release |
|
* |
Incorporated by reference herein from Form 8-K filed October 2, 2018, Exhibit 10.1 |
|
** |
Incorporated by reference herein from Form 8-K filed October 2, 2018, Exhibit 10.3 |
BIOLARGO, INC. Exhibit
EX-10.2 2 ex_131879.htm EXHIBIT 10.2 ex_131879.htm Exhibit 10.2 PROMISSORY NOTE THE SECURITIES REPRESENTED BY THIS PROMISSORY NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,…
To view the full exhibit click here
About BioLargo, Inc. (OTCMKTS:BLGO)
BioLargo, Inc. is a provider of platform technologies. The Company’s products are used to eliminate contaminants that threaten the water, health and quality of life. Its technology has commercial applications within several industries. The Company focuses on four areas: water treatment; industrial odor control applications; commercial, household and personal care products (CHAPP), and advanced wound care. Its AOS Filter combines iodine, water filter materials and electrolysis within a water filter device. It generates oxidation potential in order to oxidize and breakdown or otherwise eliminate, soluble organic contaminant, which are found in contaminated water. Its CupriDyne formula is used to deliver iodine within products. The Isan System is an automated iodine dosing system, which features controlled measuring, flow control, dosing and iodine extraction and removal technology, as well as an automatic tracking system that delivers iodine in calibrated doses.
